Oliver Reuss - Profile and Investment Details

Investor Profile

Oliver Reuss is a Venture Capital, Corporate Venture Capital, Private Equity Firm, Investor based in Germany with a diverse investment portfolio that includes companies such as Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics, Actym, eTheRNA immunotherapies, STAT-Dx, Rinri Therapeutics, Rigontec, Hookipa Pharma, Tacalyx, NBE-Therapeutics, Aelin Therapeutics, Okairos, ImCheck Therapeutics, Wellth, T-knife, Brainomix, Acousia Therapeutics, Rgenta Therapeutics, DiogenX, Cardior Pharmaceuticals, C-mo Medical Solutions, Delonix Bioworks, Bodyport, Ruipeng Pet Healthcare, Boehringer Ingelheim, Metabomed, ArmaGen Technologies, Rewind Therapeutics, HepaRegeniX, Perfood, Eyevensys, Promethera BiosciencesSentien Biotechnologies, Amal Therapeutics, Vira Therapeutics, OncoMyx Therapeutics, GLOX Therapeutics Ltd., Libra Therapeutics, Abalos Therapeutics, Perfood GmbH, AgomAb Therapeutics, . Over time, Oliver Reuss has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Oliver Reuss is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to German Startups, Health Care, Research and Development, Hospitals, High-growth Startups, Wellness, Women Founded, Enterprise Software, Fundraising, Investment Management, Business Model Innovation, Energy, Angel Investment, Digital Platforms, Chemical, Life Science, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Industrial Technology, Robotics, Cloud Computing, Venture Fundraising, Business Development, Technology, IoT, Software, Biotechnology, Clean Technology, Cosmetics, Market Research, Networking, Business Strategy, Electronic Health Records (EHR), Health and Hospital Services, Energy Tech, Innovation, FinTech, Disruptive technology, Digital Transformation, High Tech, Research, Consumer Software, Financial Education, Hardware, UK Startups, Technology Transfer, Utilities, Germany-based Startups, Health Diagnostics, Innovation Management, Digital Health, Renewable Energy, Medical, SaaS, Information Technology, B2B, Therapeutics, Advanced Materials, Machine Learning, Personal Health, Pharmaceuticals, Recycling, Risk Management may find it worthwhile to explore potential connections with Oliver Reuss, as their portfolio suggests a familiarity and interest in this area.

Understanding Oliver Reuss’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.